Transfer of IκBα gene increase the sensitivity of paclitaxel mediated with caspase 3 activation in human lung cancer cell

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 1, 2003, Pages 69-75

  Osaki, S ^a   Nakanishi, Yoichi ^a   Takayama, K ^a   Pei, X H ^a   Ueno, H ^b   Hara, N ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Anticancer drug; Chemosensitivity; I B ; Lung cancer; NF B

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ADENOVIRUS VECTOR; AMRUBICIN; ANTINEOPLASTIC AGENT; CASPASE 3; CISPLATIN; FLUOROURACIL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PACLITAXEL; VINDESINE; ANTHRACYCLINE; CASP3 PROTEIN, HUMAN; CASPASE; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RECOMBINANT PROTEIN;

ARTICLE; CANCER CELL; CELL KILLING; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSFER; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG CANCER; PRIORITY JOURNAL; ADENOCARCINOMA; ADENOVIRUS; APOPTOSIS; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY;

ADENOCARCINOMA; ADENOVIRIDAE; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL DIVISION; CISPLATIN; ENZYME ACTIVATION; GENETIC VECTORS; HUMANS; I-KAPPA B PROTEINS; LUNG NEOPLASMS; NF-KAPPA B; PACLITAXEL; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037349064     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Boring C. C., Squires T. S., Tong T., and Montgomery S.: Cancer statistics, 1994, Ca. Cancer J. Clin. 44: 7-26, 1994.
2. Nakanishi Y., Kawasaki M., Bai F., Takayama K., Pei X-H., Takano K., Inoue K., Osaki S., Hara N., and Kiyohara C.: Expression of p53 and glutathione-s-transferase-π relate to clinical drug resistance in non-small cell lung cancer, Oncology. 57: 318-323, 1999.
3. Kawasaki M., Nakanishi Y., Kuwano K., Yatsunami J., Takayama K., and Hara N.: The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer. Clin. Cancer Res. 3: 1195-200, 1997.
4. Fisher D. E.: Apoptosis in cancer therapy: crossing the threshold. Cell. 78: 539-542, 1994.
5. Fulda S., Susin S. A., Kroemer G., and Debatin K. M.: Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58: 4453-4460, 1998.
6. Kerr J. F., Winterford C. M., and Harmon B. V.: Apoptosis. Its significance in cancer and cancer therapy [published erratum appears in Cancer 1994 Jun 15;73(12):3108]. Cancer 73: 2013-2026, 1994.
7. Fujiwara T., Grimm E. A., Mukhopadhyay T., Zhang W. W., Owen-Schaub L. B., and Roth J. A.: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Research 54: 2287-2291, 1994.
8. Takayama T., Ueno H., Pei X-H., Nakanishi Y., Yatsunami J., and Hara N.: The levels of integrin αvβ5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer. Gene Therapy 5: 361-368, 1998.
9. Osaki S., Nakanishi Y., Takayama K., Pei X-H., Ueno H., and Hara N.: Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells. Cancer Gene Therapy 7: 300-307, 2000.
10. Wang C. Y., Mayo M.W., and Baldwin A.S.: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274: 784-787, 1996.
11. Beg A. A., Baltimore D.: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782-784, 1996.
12. Liu Z. G., Hsu H., Goeddel D. V., and Karin M.: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87: 565-576, 1996.
13. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Shoonhoven R., Grisham J.W., and Brenner D.A.: NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101: 802-811, 1998.
14. Jung M., Zhang Y., Dimtchev A., and Dritschilo A.: Impaired regulation of nuclear factor-kappaB results in apoptosis induced by gamma radiation. Radiat. Res. 149: 596-601, 1998.
15. Xu. Y., Bialik S., Jones B.E., limuro Y., Kitsis R.N., Srinivasan A., Brenner D.A., and Czaja M.J.: NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am. J. Physiol. 275: C1058-C1066, 1998.
16. Wang C. Y., Cusack J.C., Liu R., and Baldwin A.S.: Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nature Medicine 5: 412-417, 1999
17. Li J.J., Ueno H., Pan Y., et al.: Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc. Res. 30: 97-105, 1995.
18. Ueno H., Li J.J., Tomita H., et al.: Quantitative analysis of repeated adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler. Thromb. Vasc. Biol. 15: 2246-2253, 1995.
19. Scudiero D.A., Shoemaker R.H., Paul K.D., et al.: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48: 4827-4933, 1988.
20. Stevens M.G., Olsen S.C.: Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J. Immunol. Methods 157: 225-231, 1993.
21. Pei X-H., Nakanishi Y., Takayama K., Bai F., and Hara N.: Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor κB activity. J. Biol. Chem. 49: 35240-35246, 1999.
22. Hickman J. A.: Apoptosis induced by anticancer drugs, Cancer Metastasis Rev. 11: 121-139, 1992.
23. Souquet P.J., Chauvin F., Boissel J.P., et al.: Polychemotherapy in advanced non-small-cell lung cancer: A meta-analysis, Lancet. 342: 19-21, 1993.
24. Nemunaitis J., Swisher S.G., Timmons T. et al.: Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. Journal of Clinical Oncology 18: 609-622, 2000.
25. Bogdan C., Ding A.: Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. Journal of Leukocyte Biology 52: 119-121, 1992.
26. Ding A. H., Porteu F., Sanchez E., and Nathan C.F.: Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370-372, 1990.
27. Manthey C. L., Brandes M.E., Perera P.Y., and Vogel S.N.: Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. Journal of Immunology 149: 2459-2465, 1992.
28. Lee L.F., Lofquist A.K., Schurer-Maly C.-C., Day C., Ting J.P.-Y., White C.M., Martin B.K., and Haskill J.S.: Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res. 56: 1303-1308, 1996.
29. Collin, T.S., Lee L.F., and Ting J.P.: Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-κB and AP-1-dependent mechanism. Cancer Immunol. Immunother. 49: 78-84, 2000.
30. Baeuerle P. A.: The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochem. Biophys. Acta. 1072: 63-80, 1990.
31. Huang Y., Johnson K.R., Norris J.S., and Fan W.: Nuclear Factor-κB/IκB Signaling Pathway May Contribute to the Mediation of Paclitaxel-induced Apoptosis in Solid Tumor Cells. Cancer Res. 60: 4426-4432, 2000.
32. Jeremias I., Kupatt C., Baumann B., Herr I., Wirth T., and Debatin K.M.: Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91: 4624-4631, 1998.
33. Batra R., Guttridge D.C., Brenner D.A., Dubinett S.M., Baldwin A.S., and Boucher R.C.: IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. Am. J. Respir. Cell Mol. Biol. 21: 238-245, 1999.
34. Kawai H., Yamada Y., Tatsuka M., Niwa O., Yamamoto K., and Suzuki F.: Down-regulation of nuclear factor kappaB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes. Cancer Res. 59: 6038-6041, 1999.
35. Gururajanna B., A.-K. AA., Li Y.W., Aranha O., Vaitkevicius V.K., and Sarkar F.H.: Molecular effects of taxol and caffeine on pancreatic cancer cells. Int. J. Mol. Med. 4: 501-507, 1999.